FTSE All-Share
5.240,90
PKT
-24,84
PKT
-0,47
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.09.21 | Unilever Underweight | JP Morgan Chase & Co. | |
| 29.09.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 29.09.21 | Rio Tinto Equal-weight | Morgan Stanley | |
| 29.09.21 | Lloyds Banking Group Neutral | Goldman Sachs Group Inc. | |
| 28.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 28.09.21 | Prudential Buy | Deutsche Bank AG | |
| 28.09.21 | Unilever Buy | Goldman Sachs Group Inc. | |
| 27.09.21 | Prudential Outperform | RBC Capital Markets | |
| 27.09.21 | Vodafone Group Outperform | Credit Suisse Group | |
| 24.09.21 | AstraZeneca Overweight | Barclays Capital | |
| 24.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.09.21 | AstraZeneca Buy | UBS AG | |
| 24.09.21 | GSK Neutral | UBS AG | |
| 24.09.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 24.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 23.09.21 | Vodafone Group Buy | UBS AG | |
| 23.09.21 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 22.09.21 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 22.09.21 | Diageo Sector Perform | RBC Capital Markets | |
| 22.09.21 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 22.09.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 22.09.21 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 21.09.21 | Prudential Buy | Jefferies & Company Inc. | |
| 21.09.21 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 21.09.21 | Vodafone Group Outperform | Bernstein Research | |
| 21.09.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 21.09.21 | Prudential Buy | Jefferies & Company Inc. | |
| 20.09.21 | HSBC Neutral | JP Morgan Chase & Co. | |
| 20.09.21 | Prudential Buy | Jefferies & Company Inc. | |
| 20.09.21 | National Grid Overweight | Morgan Stanley | |
| 20.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 20.09.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.09.21 | GSK Neutral | UBS AG | |
| 17.09.21 | AstraZeneca Overweight | Morgan Stanley | |
| 17.09.21 | BP Overweight | JP Morgan Chase & Co. | |
| 17.09.21 | Barclays Overweight | JP Morgan Chase & Co. | |
| 17.09.21 | HSBC Overweight | Barclays Capital | |
| 17.09.21 | HSBC Outperform | RBC Capital Markets |